Neuromodulation for Central Post-stroke Pain: Mechanism, Safety and Outcome
RecruitingNCT05708729Phase: NAStarted 2023-01-24
Summary
Central post-stroke pain (CPSP) is an often pharmacorefractory type of neuropathic pain that develops in 8% of stroke patients. CPSP has been treated with three distinct types of neuromodulation (deep
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
70 Years
Locations
UZ LeuvenLeuven, Belgium
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05708729